Entellus Medical, a provider of minimally invasive therapeutic solutions to healthcare providers and sinusitis patients, has entered into a licensing agreement with Acclarent, in order to resolve their patent lawsuit.

As part of the agreement, the companies will file a joint request for the termination of a patent infringement proceeding brought by Acclarent against Entellus on 28 July 2010 in the US District Court for the Northern District of California.

The license agreement is royalty bearing to Acclarent and additional financial details were not disclosed.

Entellus president and CEO Brian Farley said they are pleased to have reached a mutually beneficial arrangement.